Health

  • February 13, 2026

    RFK Jr. Taps Ex-Jones Day Atty For FDA Senior Counselor

    U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. has named a former Jones Day partner as one of the U.S. Food and Drug Administration's senior counselors, according to an announcement.

  • February 13, 2026

    States' Generic Drugs Antitrust Case Headed Toward Trial

    A Connecticut federal judge has mostly refused to side with pharmaceutical companies facing states' generic drug price-fixing litigation against them, ruling that there are genuine disputes of material fact as to drug distribution chains and the states' antitrust standing and teeing up the case for trial.

  • February 13, 2026

    Health Exec Says He Was Fired For Opposing 'Enron-Style' Plot

    Jefferson Health System terminated its former vice president of facilities management over "his refusal to participate in" what he described as "an Enron-style financial engineering scheme" related to a proposed energy-as-a-service transaction that he believed posed serious regulatory risks, according to a suit filed in Pennsylvania.

  • February 13, 2026

    Ga. Judge Rejects 'Conspiracy Theories' Behind DQ Bid

    A Georgia federal judge rejected Friday a Florida couple's bid to disqualify the judge overseeing their medical malpractice case after it was tossed for using falsified video footage, writing that the effort was based on "nothing but speculative and attenuated conspiracy theories."

  • February 13, 2026

    Docs Urge Judge To Block CDC's Childhood Vaccine Changes

    Doctors organizations Friday urged a Massachusetts federal judge to stop the government from implementing its new, shorter list of recommended vaccines for children and prevent the next meeting of a committee they say has been tainted by anti-vaccine influence.

  • February 13, 2026

    Iowa AG Urges 8th Circ. To Unblock Parts Of State PBM Law

    The state of Iowa urged the Eighth Circuit on Friday to lift a preliminary block on parts of a law limiting pharmacy benefit managers' power to set drug prices in the Hawkeye State, arguing a lower court judge erred in holding that parts of the policy were federally preempted.

  • February 13, 2026

    State Lawmakers Advance Flurry Of Psilocybin Reform Bills

    Since the beginning of the year, lawmakers in several states have introduced and advanced numerous bills regarding psilocybin, the active compound in psychoactive mushrooms, including bills decriminalizing it, funding research into its medical uses and establishing a regulated medical program.

  • February 13, 2026

    Insurer Off The Hook For $2M Nursing Home Judgment

    A Georgia federal judge has rejected a family's attempts to force an insurer to pay for a $2 million personal injury judgment they secured against a nursing home, ruling the family unambiguously gave up their claims when accepting a settlement amid the nursing home's bankruptcy.

  • February 13, 2026

    Breast Surgery Patients Want ERISA Class Cert. Rethink

    A United Healthcare plan member asked a New Jersey federal judge to rethink her decision denying class certification in a suit alleging the insurer systematically refused to cover postmastectomy breast reconstruction claims, arguing the court overlooked evidence showing that common issues could be resolved on a classwide basis.

  • February 13, 2026

    FDA Removes Boxed Warnings From HRT Products

    Six menopause hormone therapies will no longer have warnings on their label about heart disease, breast cancer and dementia, after the U.S. Food and Drug Administration said it removed them so that women can make decisions "free from exaggeration or fear."

  • February 13, 2026

    Talc MDL Law Firm Accuses Litigation Funders Of Case Piracy

    A leading plaintiffs law firm in the multibillion-dollar litigation over Johnson & Johnson's tainted talcum powder has alleged in Mississippi federal court three investment firms loaned it "tens of millions" of dollars under false pretenses in a "loan-to-own" scheme.

  • February 13, 2026

    Olympus Slips Whistleblower Suit Over Testing Practices

    A Pennsylvania federal judge has dismissed a whistleblower lawsuit brought by the former head of product development for Olympus Corp. of the Americas, ruling that the ex-executive failed to show he was fired in retaliation for speaking out about what he alleged were company violations of the National Defense Authorization Act.

  • February 13, 2026

    Ga. Nursing Board Faces Suit Over Student Placement Policy

    The Georgia Board of Nursing is violating federal antitrust law with a "protectionist" policy that prevents online and out-of-state nursing programs from placing their students at Georgia facilities for clinical rotations, an online college told a federal court.

  • February 13, 2026

    J&J Hit With $250K Verdict In 2nd Philly Talc Trial

    A Philadelphia jury hit Johnson & Johnson with a $250,000 verdict on Friday, finding the company liable in the case of a woman whose family claimed that using the company's once-famous talcum powder contributed to her fatal ovarian cancer.

  • February 13, 2026

    Prenatal Testing Co. Missed Fatal Condition, Couple Say

    A Massachusetts couple say Natera Inc. misreported the results of tests for a genetic marker linked to a fatal kidney condition, leading to the conception of a child who died an hour after birth.

  • February 13, 2026

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen a former U.S. defense contractor convicted of tax evasion face legal action, French football club Olympique Lyonnais sued following a $97 million ruling against its owner John Textor, consulting giant Kroll targeted by a South African airline, and H&M hit with a claim alleging it copied protected sunglasses designs. Here, Law360 looks at these and other new claims in the U.K.

  • February 12, 2026

    Trump Admin. Blocked From Cutting $600M In Health Funding

    An Illinois federal judge on Thursday temporarily blocked the Trump administration from terminating more than $600 million in public health funding to four Democratic-led states, saying the states will likely succeed in showing they are unconstitutionally being targeted due to political or policy objectives.

  • February 12, 2026

    Super Micro Investor Fights Uphill At 9th Circ. To Lead Suit

    A Ninth Circuit panel appeared skeptical Thursday of a Super Micro Computer Inc. investor's writ of mandamus petition challenging a lower court's decision to reject it as lead plaintiff in a proposed securities class action, with each judge expressing doubts that the investor has shown its "extraordinary" request for relief is warranted.

  • February 12, 2026

    Feds Charge 2 Foreign Nationals Over $10M Healthcare Fraud

    Federal officials in Chicago announced healthcare fraud charges Thursday against two natives of Pakistan who allegedly made $10 million by using fake medical companies to submit Medicare and other health benefit claims for items and services they never provided.

  • February 12, 2026

    DC Circ. Judge Rips Into Insurer In CMS Rating Case

    A Louisiana insurer found a tough critic in one D.C. Circuit judge Thursday as it argued that the Centers for Medicare & Medicaid Services used an unfair method to assess its "star ratings" for insurance plans, with the jurist saying the company seemed like it "just wanted whatever interpretation will give you a higher score."

  • February 12, 2026

    FTC's PBM Case Paused For More Deal Talks

    Federal Trade Commission staffers are discussing potential settlements with OptumRx and Caremark that could end the agency's case accusing the pharmacy benefit managers of inflating insulin prices, following a recent deal with Express Scripts.

  • February 12, 2026

    Colo. City Faces Bias Suit For 'Sober Living' Housing Policy

    The city of Longmont, Colorado, discriminated against individuals recovering from substance abuse by requiring a private recovery housing provider to undergo a site plan approval process that others are not subjected to, the recovery residence provider alleged in federal court.

  • February 12, 2026

    Ex-Pharma Exec Fights AGs' Quick Win Bid In Antitrust Case

    A former pharmaceutical marketing executive urged a Connecticut federal court to reject summary judgment sought against him by state attorneys general pursuing wider price-fixing litigation against most of the generic drug industry, arguing key cooperating witnesses' questionable credibility makes a trial necessary.

  • February 12, 2026

    Attys Win $626K In Fees In Mich. City Retiree Benefits Suit

    A Michigan federal judge awarded $626,777.80 in attorney fees and costs to class counsel who secured expanded pension and healthcare benefits for retired Pontiac city employees, trimming $100,000 from the request for unsupported billing entries.

  • February 12, 2026

    Texas AG To Investigate Conduent, BCBS For Data Breach

    Texas Attorney General Ken Paxton announced Thursday that he's investigating Blue Cross Blue Shield of Texas and Conduent Business Services LLC over a sprawling data breach that left sensitive data for upward of four million Texans exposed.

Expert Analysis

  • AI Evidence Rule Tweaks Encourage Judicial Guardrails

    Author Photo

    Recent additions to a committee note on proposed Rule of Evidence 707 — governing evidence generated by artificial intelligence — seek to mitigate potential dangers that may arise once machine outputs are introduced at trial, encouraging judges to perform critical gatekeeping functions, say attorneys at Lankler Siffert & Wohl.

  • Series

    The Law Firm Merger Diaries: Getting The Message Across

    Author Photo

    Communications and brand strategy during a law firm merger represent a crucial thread that runs through every stage of a combination and should include clear messaging, leverage modern marketing tools and embrace the chance to evolve, says Ashley Horne at Womble Bond.

  • Opinion

    Horizontal Stare Decisis Should Not Be Casually Discarded

    Author Photo

    Eliminating the so-called law of the circuit doctrine — as recently proposed by a Fifth Circuit judge, echoing Justice Neil Gorsuch’s concurrence in Loper Bright — would undermine public confidence in the judiciary’s independence and create costly uncertainty for litigants, says Lawrence Bluestone at Genova Burns.

  • Key Takeaways From Armed Services Board's FY 2025 Report

    Author Photo

    The Armed Services Board of Contract Appeals’ annual report reveals an increase in new cases filed, but a decrease in cases resolved, and fewer parties choosing alternative dispute resolution, despite the likely reduction in time and expenses incurred during a prolonged appeal process, say attorneys at Miller & Chevalier.

  • 10 Commandments For Agentic AI Tools In The Legal Industry

    Author Photo

    Though agentic artificial intelligence has demonstrated significant promise for optimizing legal work, it presents numerous risks, so specific ethical obligations should be built into the knowledge base of every agentic AI tool used in the legal industry, says Steven Cordero at Akerman LLP.

  • New Drug Ad Regs Could Lead To A Less Informed Public

    Author Photo

    A federal push to mandate full safety warnings in pharmaceutical advertising could make drug ads less appealing for companies to air, which in turn could negatively affect consumers' health decisions by removing an accessible information source, say Punam Keller at Dartmouth College and Ceren Canal Aruoba at Berkeley Research Group.

  • Series

    Preaching Makes Me A Better Lawyer

    Author Photo

    Becoming a Gospel preacher has enhanced my success as a trial lawyer by teaching me the importance of credibility, relatability, persuasiveness and thorough preparation for my congregants, the same skills needed with judges and juries in the courtroom, says Reginald Harris at Stinson.

  • A Look At Middlemen Fees In 340B Drug Discount Program

    Author Photo

    A U.S. Senate committee's recent hearing on the Section 340B drug discount program, along with statistical analysis of payment amounts, contribute to a growing consensus that middlemen fees are too high, say William Sarraille at the University of Maryland, and Shanyue Zeng and Rory Martin at IQVIA.

  • Series

    Law School's Missed Lessons: Practicing Client-Led Litigation

    Author Photo

    New litigators can better help their corporate clients achieve their overall objectives when they move beyond simply fighting for legal victory to a client-led approach that resolves the legal dispute while balancing the company's competing out-of-court priorities, says Chelsea Ireland at Cohen Ziffer.

  • Perspectives

    Nursing Home Abuse Cases Face 3 Barriers That Need Reform

    Author Photo

    Recent headlines reveal persistent gaps in oversight and protection for vulnerable residents in long-term care, but prosecution of these cases is often stymied by numerous challenges that will require a comprehensive overhaul of regulatory, legal and financial structures to address, says Veronica Finkelstein at Wilmington University.

  • Series

    The Law Firm Merger Diaries: How To Build On Cultural Fit

    Author Photo

    Law firm mergers should start with people, then move to strategy: A two-level screening that puts finding a cultural fit at the pinnacle of the process can unearth shared values that are instrumental to deciding to move forward with a combination, says Matthew Madsen at Harrison.

  • Mulling Differing Circuit Rulings On Gender-Affirming Care

    Author Photo

    Despite the Eleventh Circuit's recent holding in Lange v. Houston County that a health plan's exclusion for gender-affirming surgery did not violate Title VII, employers should be mindful of other court decisions suggesting that different legal challenges may still apply to blanket exclusions for such care, say attorneys at Smith Gambrell.

  • Considerations When Invoking The Common-Interest Privilege

    Author Photo

    To successfully leverage the common-interest doctrine in a multiparty transaction or complex litigation, practitioners should be able to demonstrate that the parties intended for it to apply, that an underlying privilege like attorney-client has attached, and guard against disclosures that could waive privilege and defeat its purpose, say attorneys at DLA Piper.

  • Series

    The Law Firm Merger Diaries: Making The Case To Combine

    Author Photo

    When making the decision to merge, law firm leaders must factor in strategic alignment, cultural compatibility and leadership commitment in order to build a compelling case for combining firms to achieve shared goals and long-term success, says Kevin McLaughlin at UB Greensfelder.

  • Key Risks For Cos. As MAHA Influences Food Regulation

    Author Photo

    As the Make America Healthy Again movement alters state and federal legislative and regulatory priorities, measures targeting ultra-processed foods, front-of-package labeling requirements and restrictions on schools are creating new compliance and litigation risks for food and beverage manufacturers, pharmaceutical companies, retailers and digital advertisers, say attorneys at Kelley Drye.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.